Slide 1: 4Q24 & 2024 Earnings Presentation
4Q24 & 2024 Earnings Presentation March 21, 2025
Slide 2: Disclaimer
Disclaimer Forward-looking statements are exclusively related to the prospects of the business, its operating and financial results, and prospects for growth. These data are merely projections and, as such, based exclusively on our management's expectations for the future of the business and its con
Slide 3: Sell-Out growth of 9.3%
Sell-Out Sell-Out growth of 9.3% NON-RETAIL MARKET¹ RETAIL MARKET² +25,5% +8,1% in 2024 in 2024 Highlights Pain Nausea Gynecology Vitamins Nausea 3 Note: ¹Sell-out HPP, according to IQVIA; ²Sell-out PPP, according to IQVIA;
Slide 4: R$2.3 billion in investments in Marketing, Innovation and Production and Distribution Capacity
R$2.3 billion in investments in Marketing, Innovation and Production and Distribution Capacity Production and Marketing Innovation Distribution Capacity R$1.3bn R$559mn R$428mn 50+ Launches in 2024 Dist. Center Expansion Solids plant expansion Integration from acquisitions Gastro Respiratory Cardio
Slide 5: Other Highlights
Other Highlights S&P Global Sustainability Governance and Main Indexes Yearbook Sustainability Committee OBJECTIVE: created in 1Q24 to strengthen aspects of corporate governance and advise the Board of Directors in defining guidelines and actions for integrating ESG dimensions into the Company's str
Slide 6: 2024 Results (R$ million)
2024 Results (R$ million) NET REVENUE R$7,442.5 -6.0%1 (4Q24: R$1,511.0 -18.2%2) GROSS MARGIN 58.9%³ -420bps4 (4Q24: 52.0%³ -1,010bps4) MARKETING EXPENSES +6.7%1 +210bps4 (4Q24: +30.9%² +960bps4) SELLING EXPENSES +3.5%1 +120bps4 (4Q24: +1.7%² +310bps4) GENERAL AND ADMINISTRATIVE EXPENSES +5.0%1 +50b
Slide 7: 2024 Cash Flow (R$ million)
2024 Cash Flow (R$ million) 2,540 1,761 (428) (351) +6% (1,815) 2,581 vs. 2023 (787) 1,739 (7,501) (9,240) Gross Cash at the Cash Flow From PP&E Intangibles 2024 Free Cash Financing Cash Interest on Capital Gross Cash at the Gross Debt at the Net Debt at the end end of 2023 Operations Flow Flow end
Slide 8: efd
efd harma